Japan's Olympus enhances innovation capabilities by expanding R&D to Hyderabad, India

Olympus Corporation, a Japan-headquartered medtech company, has announced its strategic initiative to establish an R&D Offshore Development Center (ODC) in Hyderabad, India. This decision comes as a result of a strategic agreement with global technology company HCLTech, aimed at diversifying Olympus' innovation generation activities.

Concurrent with the creation of the ODC, Olympus will also prepare for the establishment of Olympus’ in-house R&D centre in the coming years. This centre would be in addition to the company’s current R&D centers in Japan, the United States, and Europe.

The company plans to further establish its presence in the country by collaborating with AIG Hospitals, Hyderabad for joint research projects. By partnering with one of India's premier healthcare institutions, Olympus aims to leverage clinical expertise and insights to drive the development of innovative medical solutions that address the evolving needs of patients worldwide.

Establishing this R&D ODC in Hyderabad is part of Olympus' commitment to leverage global R&D talents and resources driving advancements in medical technology. Hyderabad is a major metropolitan area and is known as India’s medtech hub, providing the talent needed for research and development activities necessary for Olympus' expansion efforts.